Phenotypic heterogeneity in Huntington disease

Area of Science:

• Neurogenetics
• Clinical Neurology
• Human Genetics

Background:

• Huntington disease (HD) is a progressive neurodegenerative disorder.
• Clinical manifestations and age of onset in HD can vary significantly between affected individuals and families.
• Understanding this variability is crucial for genetic research and patient management.

Purpose of the Study:

• To present two Huntington disease (HD) pedigrees with distinct clinical features.
• To explore potential genetic heterogeneity underlying observed clinical differences in HD.
• To discuss the implications of clinical and genetic heterogeneity for HD research and patient care.

Main Methods:

• Clinical data collection from two Huntington disease (HD) pedigrees.
• Analysis of age at onset, paternal transmission effects, and presenting symptoms.
• Comparison with previously reported HD kindreds to identify patterns of heterogeneity.

Main Results:

• Significant differences observed in mean age at onset and its distribution between the two HD pedigrees.
• Variations in the influence of paternal transmission on age at onset were noted.
• Differences in manic-depressive symptoms and initial presenting symptoms were documented.

Conclusions:

• The observed clinical heterogeneity between HD kindreds suggests possible underlying genetic heterogeneity.
• This heterogeneity may arise from mutations at a single Huntington disease (HD) locus.
• Recognizing genetic heterogeneity is vital for advancing HD research and tailoring clinical care for diverse patient populations.